Welcome guest, Sign in
Home
A major barrier for using non-viral vectors for gene therapy is the short duration of transgene expression in postmitotic tissues. Previous studies showed transgene expression from conventional plasmid fell to sub-therapeutic level shortly after delivery even though the vector DNA was retained, suggesting transcription was silenced in vivo (Nicol et al., 2002; Chen et al., 2004). Emerging evidence indicates that plasmid bacterial backbone sequences are responsible for the transcriptional repression and this process is independent of CpG methylation (Chen et al., 2008). Dumbbell-shaped DNA vectors consisting solely of essential elements for transgene expression have been developed to circumvent these drawbacks. This novel non-viral vector has been shown to improve transgene expression in vitro and in vivo (Schakowski et al., 2001 and 2007). Here we describe a novel method for fast and efficient production of minimised small RNA-expressing dumbbell vectors. In brief, the PCR-amplified promoter sequence is ligated to a chemically synthesized hairpin RNA coding DNA template to form the covalently closed dumbbell vector. This new technique may facilitate applications of dumbbell-shaped vectors for preclinical investigation and human gene therapy.
Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s). Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.
[Abstract] A major barrier for using non-viral vectors for gene therapy is the short duration of transgene expression in postmitotic tissues. Previous studies showed transgene expression from conventional plasmid fell to sub-therapeutic level shortly after delivery even though the vector DNA was retained, suggesting transcription was silenced in vivo (Nicol et al., 2002; Chen et al., 2004). Emerging evidence indicates that plasmid bacterial backbone sequences are responsible for the transcriptional repression and this process is independent of CpG methylation (Chen et al., 2008). Dumbbell-shaped DNA vectors consisting solely of essential elements for transgene expression have been developed to circumvent these drawbacks. This novel non-viral vector has been shown to improve transgene expression in vitro and in vivo (Schakowski et al., 2001 and 2007). Here we describe a novel method for fast and efficient production of minimised small RNA-expressing dumbbell vectors. In brief, the PCR-amplified promoter sequence is ligated to a chemically synthesized hairpin RNA coding DNA template to form the covalently closed dumbbell vector. This new technique may facilitate applications of dumbbell-shaped vectors for preclinical investigation and human gene therapy.
Keywords: Dumbbell vector, Minimal vector, Small RNA expression, MiRNA, shRNA, Genetic therapy
[Background] With regard to delivery, a small vector size is advantageous improving extracellular transport including extravasation and diffusion through the extracellular matrix network as well as cellular uptake and nuclear diffusion. Various methods for dumbbell vector production have been developed over the time including methods for the generation of dumbbells expressing small RNAs such as small hairpin RNAs (shRNAs) and microRNAs (miRNAs) (Schakowski et al., 2001; Taki et al. 2004). These vectors usually harbour redundant sequences as the expressed RNAs are self-complementary. We eliminated redundant sequences generating minimised dumbbell vectors in which transcription goes around the hairpin structure of the dumbbell itself (Jiang et al., 2016). Such minimised dumbbell vectors can be as short as 130 bp representing the smallest expression vectors ever reported. An illustrated comparison between a conventional plasmid, a dumbbell harbouring a linear expression cassette, and a novel hairpin template-transcribing dumbbell vector is shown in Figure 1. This novel protocol facilitates the production of the new minimised small RNA expression dumbbell vectors..Figure 1. Structures of small hairpin RNA-expressing plasmid and dumbbell vectors. Upper two: conventional plasmid p-iPR-linear-s/as and dumbbell db-iPR-linear-s/as vectors with linear shRNA expression cassettes and integrated promoter-restriction endonuclease site element (iPR). Lower vector: minimized hairpin template (hp) dumbbell harboring an iPRT element. R indicates a restriction overhang ligation site. T indicates termination signal. IT indicates inverted termination signal. Loops L1 and L2 are (T)4 tetra loops.
Materials and Reagents
Equipment
Software
Procedure
In this protocol we describe a method for the production of a) shRNA (example db-iPRT-hp-s/as: targeting luciferase) or b) miRNA (example db-hp-miR-125b-1: expressing has-miR-125b-1) expressing minimised dumbbell vectors (Jiang et al., 2016). For these dumbbells, shRNA or miRNA expression is driven by the human minimal H1 (mH1) promoter. The mH1 promoter is PCR-amplified using a forward primer which introduces a cleavage site for a nicking endonuclease and a reverse primer introducing a cleavage site for a conventional restriction endonuclease. After incubating the PCR product with both endonucleases, one loop structure of the dumbbell is formed by the refolding overhang generated by the nicking reaction, whereas the other loop is formed by ligation of a shRNA or miRNA-coding hairpin oligodeoxyribonucleotide. Ligation is performed in the presence of appropriate restriction enzymes to suppress the formation of misligated products (Cost, 2007). The enzymatic ligation assisted by nucleases (ELAN) method suppresses the formation of misligated products such as dimers composed of the loop oligos or the expression cassette which are being cleaved in the presence of restriction endonuclease (in this example BamHI and BglII), thereby facilitating the formation of the intended dumbbell structure which doesn’t comprise the respective endonuclease cleavage sites. Finally, non-ligated DNA is destroyed by exonuclease treatment and exonuclease-resistant dumbbells are purified (Figure 2). Figure 2. Production strategy for small RNA-expressing minimized dumbbell vectors. The protocol consists of the following steps: First, the mH1 promoter sequence is amplified by PCR. Proper nicking enzyme (NE) and conventional restriction (RE) sites are introduced via the PCR primers. Second, the amplified promoter DNA is digested using the corresponding nicking and restriction enzymes. Third, the digested DNA is purified, and fourth annealed and ligated with the hairpin DNA template oligo using T4 DNA ligase to form an shRNA (left side) or miRNA (right side) expressing dumbbell vector. The addition of a neutralizing oligo and the column purification step significantly improve dumbbell yields. Finally, non-ligated DNA is removed by exonuclease treatment and dumbbell vector DNA is purified using standard DNA purification techniques (Jiang et al., 2016).
Data analysis
Analysis of dumbbell DNA conversion yield:
Notes
Recipes
Acknowledgments
The protocol described herein was developed and utilized previously in Jiang et al. (2016). This work was supported by the National University of Singapore [Bridging Grant NUHSRO/2015/091/Bridging/02], the National Medical Research Council of Singapore [New Investigator Grant number NMRC/NIG/1058/2011], and the Ministry of Education of Singapore [Academic Research Fund (AcRF) Tier 1 Faculty Research Committee (FRC) grants number T1-2011Sep-04 and T1-2014Apr-02 and Seed Fund for Basic Science Research number T1-BSRG 2015-05], all to VP. The authors declare competing financial interests. A patent application covering major parts of the work is pending.
References
Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.
Login | Register
View Original Delete
Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol. You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.